---
title: "Lenvatinib - Papillary Thyroid Carcinoma - 2"
sidebar: mydoc_sidebar
permalink: db09078-mesh-d000077273-2.html
toc: false 
---


Path ID: `DB09078_MESH_D000077273_2`
{% include image.html url="images/db09078-mesh-d000077273-2.png" file="db09078-mesh-d000077273-2.png" alt="db09078-mesh-d000077273-2" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C531958 | lenvatinib | Drug |
| InterPro:IPR016248 | Fibroblast growth factor receptor | GeneFamily |
| GO:0009987 | cellular processes | BiologicalProcess |
| CL:0001064 | cancer cell | Cell |
| MESH:D000077273 | Papillary thyroid carcinoma | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Lenvatinib | DECREASES ACTIVITY OF | Fibroblast Growth Factor Receptor |
| Fibroblast Growth Factor Receptor | DISRUPTS | Cellular Processes |
| Cellular Processes | LOCATED IN | Cancer Cell |
| Cancer Cell | PARTICIPATES IN | Papillary Thyroid Carcinoma |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB09078#mechanismofaction](https://go.drugbank.com/drugs/DB09078#mechanismofaction)
